GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GNI Group Ltd (FRA:3G6) » Definitions » Gross Margin %

GNI Group (FRA:3G6) Gross Margin % : 77.85% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is GNI Group Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. GNI Group's Gross Profit for the three months ended in Dec. 2023 was €27.1 Mil. GNI Group's Revenue for the three months ended in Dec. 2023 was €34.8 Mil. Therefore, GNI Group's Gross Margin % for the quarter that ended in Dec. 2023 was 77.85%.


The historical rank and industry rank for GNI Group's Gross Margin % or its related term are showing as below:

FRA:3G6' s Gross Margin % Range Over the Past 10 Years
Min: 66.05   Med: 84.42   Max: 87.39
Current: 86.24


During the past 13 years, the highest Gross Margin % of GNI Group was 87.39%. The lowest was 66.05%. And the median was 84.42%.

FRA:3G6's Gross Margin % is ranked better than
80.97% of 741 companies
in the Biotechnology industry
Industry Median: 59.43 vs FRA:3G6: 86.24

GNI Group had a gross margin of 77.85% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for GNI Group was 0.50% per year.


GNI Group Gross Margin % Historical Data

The historical data trend for GNI Group's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GNI Group Gross Margin % Chart

GNI Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.89 84.18 87.39 84.65 86.24

GNI Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.53 86.37 92.24 84.06 77.85

Competitive Comparison of GNI Group's Gross Margin %

For the Biotechnology subindustry, GNI Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GNI Group's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GNI Group's Gross Margin % distribution charts can be found below:

* The bar in red indicates where GNI Group's Gross Margin % falls into.



GNI Group Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

GNI Group's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=142.9 / 165.658
=(Revenue - Cost of Goods Sold) / Revenue
=(165.658 - 22.797) / 165.658
=86.24 %

GNI Group's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=27.1 / 34.791
=(Revenue - Cost of Goods Sold) / Revenue
=(34.791 - 7.706) / 34.791
=77.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


GNI Group  (FRA:3G6) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

GNI Group had a gross margin of 77.85% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


GNI Group Gross Margin % Related Terms

Thank you for viewing the detailed overview of GNI Group's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


GNI Group (FRA:3G6) Business Description

Traded in Other Exchanges
Address
Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1030
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

GNI Group (FRA:3G6) Headlines

No Headlines